ADJUVANT CHEMOTHERAPY OF BREAST CANCER: DO WE STILL NEED ANTHRACYCLINES? Molecular Predictors of Response to Anthracyclines Angelo Di Leo, Sara Licitra, Wederson Claudino, and Laura Biganzoli ASCO EDUCATIONAL BOOK; 2008 3–7 [Overview] [Full Text] [PDF]
ENDOCRINE THERAPY OF BREAST CANCER IN THE ADJUVANT SETTING Overview of Current Approaches to Adjuvant Endocrine Therapy Stefan Aebi and Manuela Rabaglio ASCO EDUCATIONAL BOOK; 2008 9–13 [Overview] [Full Text] [PDF] Factors Predicting Response and Resistance to Endocrine Therapy of Breast Cancer Mitchell Dowsett ASCO EDUCATIONAL BOOK; 2008 14–17 [Overview] [Full Text] [PDF] Adjuvant Endocrine Therapy of the Future: Potential and Possibilities Kathleen I. Pritchard ASCO EDUCATIONAL BOOK; 2008 18–23 [Overview] [Full Text] [PDF]
HER2-TARGETED THERAPY: WHY BOTHER TESTING? HER2 as a Predictive Marker: Why Bother Testing? Antonio C. Wolff, Soonmyung Paik, and Michael F. Press ASCO EDUCATIONAL BOOK; 2008 25–28 [Overview] [Full Text] [PDF]
MOLECULAR DIAGNOSTICS IN BREAST CANCER: PROGNOSIS AND PREDICTION Markers for Predicting and Evaluating Response to Therapy for Breast Cancer Daniel F. Hayes ASCO EDUCATIONAL BOOK; 2008 30–34 [Overview] [Full Text] [PDF]
PRESERVATION OF FERTILITY IN PREMENOPAUSAL WOMEN RECEIVING SYSTEMIC TREATMENT FOR BREAST CANCER Fertility Preservation Considerations in Young Women with Breast Cancer Ann H. Partridge ASCO EDUCATIONAL BOOK; 2008 36–38 [Overview] [Full Text] [PDF] Ovarian Failure after Chemotherapy for Breast Cancer and the Role of Gonadotropin-releasing Hormone Analogs in Protection of Ovarian Function Halle C. F. Moore ASCO EDUCATIONAL BOOK; 2008 39–42 [Overview] [Full Text] [PDF] Fertility Preservation Options for Young Women with Cancer Kutluk Oktay ASCO EDUCATIONAL BOOK; 2008 43–47 [Overview] [Full Text] [PDF]
RADIOTHERAPY OF BREAST CANCER: IS LESS MORE? Changing Concepts in Radiation Therapy for Early Breast Cancer Krystyna Kiel ASCO EDUCATIONAL BOOK; 2008 49–53 [Overview] [Full Text] [PDF]
WHAT CAN WE LEARN ABOUT BREAST CANCER FROM NEOADJUVANT SYSTEMIC THERAPY? Neoadjuvant Therapy for Breast Cancer Matthew J. C. Ellis ASCO EDUCATIONAL BOOK; 2008 55–57 [Overview] [Full Text] [PDF]
NEW MODELS FOR ASSESSMENT OF HEREDITARY CANCER RISK Risk Quantification for Carrying Mutations in Lynch Syndrome Genes Judith Balmaña, Ewout W. Steyerberg, and Sapna Syngal ASCO EDUCATIONAL BOOK; 2008 59–64 [Overview] [Full Text] [PDF]
COHORT IDENTIFICATION FOR CANCER PREVENTION AND EARLY DETECTION: RISK IN THE BALANCE Identification of High-risk Cohorts for Head and Neck Cancer Prevention Based on Tissue Markers LOH and cyclin D1 William N. William, Jr. and Vassiliki A. Papadimitrakopoulou ASCO EDUCATIONAL BOOK; 2008 66–68 [Overview] [Full Text] [PDF]
SINGLE NUCLEOTIDE POLYMORPHISMS, CLINICAL TRIALS, AND TOBACCO RESEARCH: SEARCH FOR THE SMOKING GUN The Genetics of Nicotine Addiction: Current Status and Future Directions Gary E. Swan and Christina N. Lessov-Schlaggar ASCO EDUCATIONAL BOOK; 2008 70–73 [Overview] [Full Text] [PDF] Role of CYP2A6 Genetic Variation on Smoking Behaviors and Clinical Implications Man Ki Ho and Rachel F. Tyndale ASCO EDUCATIONAL BOOK; 2008 74–78 [Overview] [Full Text] [PDF]
THE GROWING CHALLENGE OF CNS METASTASES: NEW THERAPEUTIC APPROACHES Leptomeningeal Metastases: Still a Challenge Morris D. Groves ASCO EDUCATIONAL BOOK; 2008 80–87 [Overview] [Full Text] [PDF]
BEYOND RECIST: MEANINGFUL AND ACCEPTABLE ENDPOINTS IN PHASE II TRIALS Tumor Burden Endpoints and Phase II Clinical Trial Design Walter M. Stadler ASCO EDUCATIONAL BOOK; 2008 89–93 [Overview] [Full Text] [PDF]
EARLY DATA: PRESENTING AND PUBLISHING PRELIMINARY RESULTS Group Sequential Stopping Rules for Clinical Trials: A Statistical Guide to Acting on Early Results Donna S. Neuberg ASCO EDUCATIONAL BOOK; 2008 95–99 [Overview] [Full Text] [PDF]
ENDPOINTS FOR IMMUNOTHERAPY STUDIES: DESIGN AND REGULATORY IMPLICATION Immunotherapies with Other Therapeutic Modalities: New Paradigms for Clinical Trial Design Jeffrey Schlom, Philip M. Arlen, and James L. Gulley ASCO EDUCATIONAL BOOK; 2008 101–106 [Overview] [Full Text] [PDF]
THE END OF P VALUES? WHY ALTERNATIVE METHODS TO MAKING INFERENCES MAY BE SUPERIOR Credibility Threshold: Making Efficacy Study Data Generalizable Steven Hirschfeld ASCO EDUCATIONAL BOOK; 2008 108–111 [Overview] [Full Text] [PDF]
C-MET INHIBITION FOR CANCER TREATMENT c-Met Receptor Tyrosine Kinase as a Therapeutic Target in Cancer Ravi Salgia ASCO EDUCATIONAL BOOK; 2008 113–118 [Overview] [Full Text] [PDF]
DEVELOPMENTAL THERAPEUTIC APPROACHES TO TRIPLE-NEGATIVE BREAST CANCER Evolving Strategies for the Treatment of "Triple-Negative" Breast Cancer Ethan J. Wasserman and Antoinette R. Tan ASCO EDUCATIONAL BOOK; 2008 120–126 [Overview] [Full Text] [PDF]
DNA REPAIR MODULATORS DNA Repair Modulators as Anticancer Agents Yves Pommier ASCO EDUCATIONAL BOOK; 2008 128–133 [Overview] [Full Text] [PDF]
COMMUNICATING PROGNOSIS: HOW ONCOLOGISTS CAN BE MORE EFFECTIVE Discussing Prognosis Anthony L. Back, Robert M. Arnold, and James A. Tulsky ASCO EDUCATIONAL BOOK; 2008 135–138 [Overview] [Full Text] [PDF]
ERYTHROPOIETIN STIMULATING AGENTS USE AND OVERUSE: HOW DO ONCOLOGISTS NEGOTIATE CONFLICTING DEMANDS? Role of Erythropoietin-stimulating Agents in the Outcomes of Patients with Cancer Kelly A. May and Fadlo R. Khuri ASCO EDUCATIONAL BOOK; 2008 140–144 [Overview] [Full Text] [PDF]
2007-2008 LOWER GASTROINTESTINAL OVERVIEW: PRACTICE IMPLICATIONS Radiation Therapy Combined with Novel Chemotherapy Regiments and Targeted Agents for Patients with Rectal Cancer Claus Rödel ASCO EDUCATIONAL BOOK; 2008 146–151 [Overview] [Full Text] [PDF]
INTRAPERITONEAL TREATMENT FOR GASTROINTESTINAL CANCER: ROLE OF DEBULKING AND CHEMOTHERAPY Overview of Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Dissemination of Appendiceal and Colorectal Neoplasms Edward A. Levine, Brigitte M. Ronnett, Paul F. Mansfield, and Cathy Eng ASCO EDUCATIONAL BOOK; 2008 153–159 [Overview] [Full Text] [PDF]
THE MULTIDISCIPLINARY MANAGEMENT OF COLORECTAL CANCER LIVER METASTASES Radiation Therapy for Liver Metastases Laura A. Dawson ASCO EDUCATIONAL BOOK; 2008 161–164 [Overview] [Full Text] [PDF]
PICKING THE WINNERS THROUGH BIOMARKER ENRICHMENT: COULD THIS BE THE END OF PHASE III TRIALS? Validated and Qualified Biomarkers Are Critical to Optimizing Anticancer Drug Development: Potential Roles for the Study of Circulating Tumor Cells Craig P. Carden, David Olmos, and Johann S. de Bono ASCO EDUCATIONAL BOOK; 2008 166–170 [Overview] [Full Text] [PDF]
RESECTABLE ESOPHAGEAL, GASTROESOPHAGEAL JUNCTION, AND GASTRIC CANCERS: SHOULD WE TREAT THEM ALL THE SAME? Resectable Esophageal, Gastroesophageal Junction, and Gastric Cancers: Therapy Is Distinct for Gastric Cancer Jimmy Hwang ASCO EDUCATIONAL BOOK; 2008 172–176 [Overview] [Full Text] [PDF] Combined Modality Therapy for Gastric, Esophageal, and Gastroesophageal Junction Cancers David H. Ilson ASCO EDUCATIONAL BOOK; 2008 177–182 [Overview] [Full Text] [PDF] Stage-specific Therapy for Esophageal Cancer: The Role of Multimodality Therapy Mark J. Krasna ASCO EDUCATIONAL BOOK; 2008 e19–e22 [Overview] [Full Text] [PDF]
UPPER GASTROINTESTINAL OVERVIEW 2007-2008: PRACTICE IMPLICATIONS OF THE NEWEST DATA Latest Data on the Treatment of Upper Gastrointestinal Cancers Johanna C. Bendell ASCO EDUCATIONAL BOOK; 2008 184–190 [Overview] [Full Text] [PDF]
RATIONAL STRATEGIES FOR THE CHOICE OF THERAPY FOR PATIENTS WITH METASTATIC KIDNEY CANCER Rational Therapeutic Choices and Strategies for Patients with Metastatic Renal Cancer W. Kimryn Rathmell, Walter M. Stadler, and Brian I. Rini ASCO EDUCATIONAL BOOK; 2008 192–198 [Overview] [Full Text] [PDF]
SYSTEMIC THERAPY FOR MUSCLE INVASIVE BLADDER CANCER: WHO SHOULD RECEIVE CHEMOTHERAPY AND WHEN Muscle-invasive Bladder Cancer: What Have We Learned and What's New on the Horizon? Christopher Sweeney, Dean F. Bajorin, and Cora N. Sternberg ASCO EDUCATIONAL BOOK; 2008 200–208 [Overview] [Full Text] [PDF]
ADJUVANT THERAPY FOR OLDER ADULTS WITH BREAST AND COLON CANCERS: PHARMACOLOGY AND DECISION MAKING Pharmacology of Antineoplastic Agents for Older Patients Stuart M. Lichtman ASCO EDUCATIONAL BOOK; 2008 210–214 [Overview] [Full Text] [PDF]
EVALUATING, TREATING, AND SUPPORTING OLDER ADULTS WITH ACUTE LEUKEMIAS Acute Leukemia in Older Adults: Are We Treating Too Much or Too Little? Maria R. Baer, Heidi D. Klepin, and Andrew S. Artz ASCO EDUCATIONAL BOOK; 2008 216–223 [Overview] [Full Text] [PDF]
ADVANCES IN THE MANAGEMENT OF OVARIAN CANCER Management of Stromal Tumors of the Ovary Judith K. Wolf and Jubilee Brown ASCO EDUCATIONAL BOOK; 2008 225–228 [Overview] [Full Text] [PDF]
ADVANCES IN THE MANAGEMENT OF UTERINE CANCER Adjuvant Therapy for High-risk Adenocarcinoma of the Uterus Gini Fleming ASCO EDUCATIONAL BOOK; 2008 230–233 [Overview] [Full Text] [PDF]
HYPOTHESIS, EVIDENCE, AND EXPERIENCE IN CHOOSING SEQUENTIAL CHEMORADIATION FOR ADVANCED HEAD AND NECK CANCER Sequential Chemoradiation for Squamous Cell Carcinoma of the Head and Neck Merrill S. Kies, George R. Blumenschein, Jr., and David Ira Rosenthal ASCO EDUCATIONAL BOOK; 2008 235–238 [Overview] [Full Text] [PDF]
CANCER AND THROMBOSIS I: THE RISK OF VENOUS THROMBOEMBOLISM (VTE) IN CANCER PATIENTS The Risk of Venous Thromboembolism in Patients with Cancer Alok A. Khorana, Howard A. Liebman, Richard H. White, Theodore Wun, and Gary H. Lyman ASCO EDUCATIONAL BOOK; 2008 240–248 [Overview] [Full Text] [PDF]
CANCER AND THROMBOSIS II: THE PREVENTION OF VENOUS THROMBOEMBOLISM (VTE) IN CANCER PATIENTS Prevention of Venous Thromboembolism in Patients with Cancer Charles W. Francis, Ajay K. Kakkar, Mark N. Levine, and Gary H. Lyman ASCO EDUCATIONAL BOOK; 2008 250–256 [Overview] [Full Text] [PDF]
CANCER AND THROMBOSIS III: THE ROLE OF ANTICOAGULATION IN THE TREATMENT OF CANCER PATIENTS Anticoagulation in the Treatment of Venous Thromboembolism in Patients with Cancer Anna Falanga, Agnes Y. Y. Lee, Michael B. Streiff, and Gary H. Lyman ASCO EDUCATIONAL BOOK; 2008 258–268 [Overview] [Full Text] [PDF]
CANCER CARE IN MINORITY POPULATIONS Disparities in Cancer Care Derek Raghavan, Edith A. Perez, and Harold A. Harvey ASCO EDUCATIONAL BOOK; 2008 270–273 [Overview] [Full Text] [PDF]
ADVANCES IN ACUTE LEUKEMIA THERAPY Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia: On Target to Improve Outcome Meir Wetzler ASCO EDUCATIONAL BOOK; 2008 275–279 [Overview] [Full Text] [PDF] Genetically Defined Prognostic Factors and Novel Therapeutics for AML Richard M. Stone ASCO EDUCATIONAL BOOK; 2008 280–284 [Overview] [Full Text] [PDF]
ADVANCES IN CHRONIC LYMPHOCYTIC LEUKEMIA FROM BIOLOGY TO BEDSIDE Chronic Lymphocytic Leukemia: Prognostic Markers and Revised Criteria for Treatment and Response Assessment Thomas J. Kipps ASCO EDUCATIONAL BOOK; 2008 286–290 [Overview] [Full Text] [PDF] The Role of Stem Cell Transplantation in Chronic Lymphocytic Leukemia John G. Gribben ASCO EDUCATIONAL BOOK; 2008 291–296 [Overview] [Full Text] [PDF] Treatments for Patients with Chronic Lymphocytic Leukemia William G. Wierda ASCO EDUCATIONAL BOOK; 2008 297–305 [Overview] [Full Text] [PDF]
CHRONIC MYELOID LEUKEMIA: THE POSTER CHILD OF TARGETED THERAPY ACHIEVES ADOLESCENCE Imatinib and Beyond—Therapy of CML in 2008 Jorge E. Cortes ASCO EDUCATIONAL BOOK; 2008 307–312 [Overview] [Full Text] [PDF] State-of-the-art Monitoring for Patients with Chronic Myeloid Leukemia Giuseppe Saglio, Fabrizio Pane, and Giovanni Martinelli ASCO EDUCATIONAL BOOK; 2008 313–317 [Overview] [Full Text] [PDF] Imatinib Resistance and the Difficulty of Eradicating Leukemia Stem Cells Michael W.N. Deininger ASCO EDUCATIONAL BOOK; 2008 318–323 [Overview] [Full Text] [PDF]
HEMATOPOIETIC STEM CELL TRANSPLANTATION AND CELLULAR IMMUNE THERAPY FOR BLOOD CANCERS Indications for Hematopoietic Cell Transplantation for the Treatment of Adult Acute Leukemia Frederick R. Appelbaum ASCO EDUCATIONAL BOOK; 2008 325–329 [Overview] [Full Text] [PDF] Leukemia Vaccines to Boost the Graft-versus-Leukemia Effect after Allogeneic Stem Cell Transplantation A. John Barrett ASCO EDUCATIONAL BOOK; 2008 330–333 [Overview] [Full Text] [PDF] Donor Lymphocyte Infusion after Allogeneic Stem Cell Transplantation Stephen Mackinnon ASCO EDUCATIONAL BOOK; 2008 334–337 [Overview] [Full Text] [PDF]
MYELOPROLIFERATIVE DISORDERS AT THE CUTTING EDGE Integration of Histology and Genetics in the Diagnosis and Classification of Myeloproliferative Neoplasms James W. Vardiman ASCO EDUCATIONAL BOOK; 2008 339–345 [Overview] [Full Text] [PDF] Management of Myeloproliferative Neoplasms and the Promise of Targeted Therapy Ayalew Tefferi ASCO EDUCATIONAL BOOK; 2008 346–348 [Overview] [Full Text] [PDF]
BIOMARKERS OF RESISTANCE AND RESPONSE IN NON-SMALL CELL LUNG CANCER Genes Predictive of Chemotherapeutic Efficacy in Non-small Cell Lung Cancer Gerold Bepler ASCO EDUCATIONAL BOOK; 2008 350–352 [Overview] [Full Text] [PDF]
NEW DEVELOPMENTS IN MANAGEMENT OF MALIGNANT MESOTHELIOMA New Biomarkers, Surgical Controversies, and Rationally Targeted Therapies for Malignant Mesothelioma Hedy Lee Kindler, Raphael Bueno, and Joseph R. Testa ASCO EDUCATIONAL BOOK; 2008 354–361 [Overview] [Full Text] [PDF]
TARGETED AND NOVEL AGENTS IN SMALL CELL LUNG CANCER Novel and Targeted Agents for Small Cell Lung Cancer Bruce E. Johnson, Charles M. Rudin, and Ravi Salgia ASCO EDUCATIONAL BOOK; 2008 363–367 [Overview] [Full Text] [PDF]
EMERGING TARGETED THERAPIES IN NON-SMALL CELL LUNG CANCER Emerging Therapies for Non-small Cell Lung Cancer Paul A. Bunn, Jr., Eric B. Haura, and John V. Heymach ASCO EDUCATIONAL BOOK; 2008 e5–e14 [Overview] [Full Text] [PDF]
INITIAL THERAPY FOR MULTIPLE MYELOMA: CONSIDERATIONS FOR AN INTEGRATED RISK-ADAPTED APPROACH Controversies Surrounding the Initial Treatment of Multiple Myeloma S. Vincent Rajkumar and Suzanne R. Hayman ASCO EDUCATIONAL BOOK; 2008 369–374 [Overview] [Full Text] [PDF] Initial Therapy for Multiple Myeloma: Role of Stem Cell Transplantation Jean-Paul Fermand ASCO EDUCATIONAL BOOK; 2008 375–379 [Overview] [Full Text] [PDF] A Risk-adapted Approach to Myeloma Therapy A. Keith Stewart ASCO EDUCATIONAL BOOK; 2008 380–384 [Overview] [Full Text] [PDF]
THE ROLE OF MAINTENANCE THERAPY IN FOLLICULAR LYMPHOMA: PROS AND CONS Maintenance Rituximab–Should It Be Given to Every Patient with Follicular Lymphoma? Julie M. Vose ASCO EDUCATIONAL BOOK; 2008 386–390 [Overview] [Full Text] [PDF]
TREATMENT OF AGGRESSIVE B-CELL LYMPHOMAS New Therapeutic Strategies for Mantle Cell Lymphoma Brad S. Kahl ASCO EDUCATIONAL BOOK; 2008 392–397 [Overview] [Full Text] [PDF]
MELANOMA: EVALUATION AND MANAGEMENT OF SPECIAL POPULATIONS Melanoma in Older Patients Julie R. Lange and Charles M. Balch ASCO EDUCATIONAL BOOK; 2008 399–402 [Overview] [Full Text] [PDF]
TARGETING NOVEL PATHWAYS IN MELANOMA New Potential Therapeutic Targets in Melanoma Thomas F. Gajewski, Elizabeth A. Grimm, Brian
